DOXORUBICINE TEVA 200 mg/100 mL, solution injectable — 1 flacon(s) en verre de 100 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400955948957 -
CIP7
5594895 -
CIS
69467732
What the source publishes
- Holder
- TEVA SANTE
- Active ingredients
- CHLORHYDRATE DE DOXORUBICINE
- Form
- solution injectable
- Package
- 1 flacon(s) en verre de 100 ml
- Routes
- intraveineuse
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 1996-02-26
- Prescription
- Prescription or restricted
Names this record is found by
- DOXORUBICINE TEVA 200 mg/100 mL, solution injectable — 1 flacon(s) en verre de 100 ml
- DOXORUBICINE TEVA 200 mg/100 mL, solution injectable
- CHLORHYDRATE DE DOXORUBICINE
Complete source data
{
"cis": "69467732",
"cip7": "5594895",
"form": "solution injectable",
"name": "DOXORUBICINE TEVA 200 mg/100 mL, solution injectable — 1 flacon(s) en verre de 100 ml",
"cip13": "3400955948957",
"holder": "TEVA SANTE",
"routes": [
"intraveineuse"
],
"holders": [
"TEVA SANTE"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": "Warning disponibilité",
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "1996-02-26",
"compositions": [
{
"name": "CHLORHYDRATE DE DOXORUBICINE",
"nature": "SA",
"strength": "200 mg",
"linkageNumber": "1",
"substanceCode": "03236",
"dosageReference": "un flacon",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "DOXORUBICINE TEVA 200 mg/100 mL, solution injectable",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "1 flacon(s) en verre de 100 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2025-02-19",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE DE DOXORUBICINE"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400955948957"